Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Gérard Marguerie | M | - |
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | - |
Jean-Louis Falco | M | - |
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | - |
Björn Dellgren | M | - |
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | - |
Caroline Roussel | F | - |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | 29 Jahre |
Jeannette Fareh | M | - |
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Caroline Roussel-Maupetit | F | - |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | 10 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Frankreich | 6 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michel Kaczorek
- Persönliches Netzwerk